Literature DB >> 7105633

Hyperoxaluria in idiopathic calcium stone disease: further evidence of intestinal hyperabsorption of oxalate.

M Marangella, B Fruttero, M Bruno, F Linari.   

Abstract

1. Seventeen healthy controls and 63 patients with idiopathic calcium stone disease of the urinary tract were investigated for urinary calcium and oxalate excretion and for [14C]oxalate intestinal absorption. 2. Under comparable controlled dietary intake a significant increase in calcium excretion as found in patients with stone disease. Oxalate excretion and [14C]oxalate intestinal absorption were mildly but not significantly increased. When patients with stone disease were subdivided into normocalciuric and hypercalciuric subjects, oxalate excretion and [14C]oxalate absorption were significantly increased in the latter. There was a significant direct relationship between calcium excretion and both oxalate excretion and [14C]oxalate absorption. 3. [14C]Oxalate absorption increased significantly in 22 stone-formers when dietary calcium was changed from normal to low. 4. The kinetics of [14C]oxalate intestinal absorption showed that the main difference between normocalciuric and hypercalciuric subjects occurred within the first 6 h after the oxalate-labelled meal. 5. These results confirm that mild hyperoxaluria is a frequent feature of idiopathic calcium stone disease even when patients and controls are studied under controlled dietary conditions. Our data are consistent with the hypothesis that hyperoxaluria is secondary to calcium hyperabsorption and is upper intestinal in origin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105633     DOI: 10.1042/cs0630381

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

1.  Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.

Authors:  John C Lieske; William J Tremaine; Claudio De Simone; Helen M O'Connor; Xujian Li; Eric J Bergstralh; David S Goldfarb
Journal:  Kidney Int       Date:  2010-08-25       Impact factor: 10.612

Review 2.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

3.  Oxalate transport by anion exchange across rabbit ileal brush border.

Authors:  R G Knickelbein; P S Aronson; J W Dobbins
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

4.  The general practitioner and nephrolithiasis.

Authors:  Emanuele Croppi; Federica Cioppi; Corrado Vitale
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

Review 5.  Nephropathy in dietary hyperoxaluria: A potentially preventable acute or chronic kidney disease.

Authors:  Robert H Glew; Yijuan Sun; Bruce L Horowitz; Konstantin N Konstantinov; Marc Barry; Joanna R Fair; Larry Massie; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2014-11-06

Review 6.  Urolithiasis in children: current medical management.

Authors:  J Laufer; H Boichis
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 7.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

8.  Noradrenaline: a circulating inhibitor of sodium transport.

Authors:  A Riozzi; A M Heagerty; R F Bing; H Thurston; J D Swales
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-20

Review 9.  A review of the heritability of idiopathic nephrolithiasis.

Authors:  D G Griffin
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

10.  Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients.

Authors:  Renato Ribeiro Nogueira Ferraz; Natália Cristina Marques; Leila Froeder; Viviane Barcellos Menon; Priscila Reina Siliano; Alessandra Calábria Baxmann; Ita Pfeferman Heilberg
Journal:  Urol Res       Date:  2009-02-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.